Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRrhTSH plus radioiodine versus radioiodine alone for multinodular goiter
2005-004451-35Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of thyrotropin alfa in multinodular goiter (MNG) (3 arms), sponsored by Sanofi. Primary endpoints: Goiter volume reduction and Dose-response in goiter shrinkage. Started Jan 2007; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
multinodular goiter (MNG)
Beyond the preview
Go deeper on 2005-004451-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004451-35.